The United States Pharmacopeia Addresses the Issue of Leachables and Extractables
Posted on April 10, 2015
By: Daniel Norwood, Distinguished Research Fellow
Boehringer Ingelheim Pharmaceuticals, Inc.
Introduction Of all the various types of impurities that can appear in drug product formulations, leachables are perhaps the most challenging to characterise, evaluate/qualify and control. This is because, unlike drug substance and formulation related impurities and degradation products, leachables ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















